Use of antagonists of plasminogen activator inhibitor-1 (PAI-1) for the treatment of asthma and chronic obstructive pulmonary disease
   
   

The invention relates to methods for treatment of asthma and chronic obstructive pulmonary disease (COPD) by administration of antagonists to plasminogen activator inhibitor type-1 (PAI-1). Suitable atagonists include antibodies, peptides, proteins, nucleic acids, small organic molecules and polymers.

 
Web www.patentalert.com

< Method for delivering benzindene prostaglandins by inhalation

< Methods for imaging pulmonary and cardiac vasculature and evaluating blood flow using dissolved polarized 129Xe

> Treatment of cancers by inhalation of stable platinum-containing formulations

> Valved fenestrated tracheotomy tube having outer and inner cannulae
~ 00121